Today’s guest is Adam Burns, Vice President of Network and Edge and director of EdgeAI Development Tools at Intel. Adam returns to the podcast this week to talk about out-of-the-box solutions for computer vision in manufacturing, retail, healthcare, and beyond. Throughout the episode, Adam discusses relevant use cases related to Intel’s Geti Platform, what industry leaders should know before deploying out-of-the-box AI products, and the essential lessons in model development he’s gained from developing these tools. If you’ve enjoyed or benefited from some of the insights of this episode, consider leaving us a five-star review on Apple Podcasts, and let us know what you learned, found helpful, or liked most about this show!

Today’s guest is Gianni Giacomelli, Former Senior Advisor for Innovation at Genpact. Gianni currently serves as Head of Design Innovation at the Collective Intelligence Design Lab at MIT. He served as Chief Innovation Officer at Genpact from 2016 to 2022, when he stepped down to found Supermind. Design, an innovation advisory firm that helps organizations engaged in environmental and social transformation harness the power of AI tools. Gianni joins us on today’s program for a sober yet optimistic conversation with Emerj CEO and Head of Research Daniel Faggella on the real-world implications for generative AI, the massive changes it will bring about for multiple industries in the near future, and what business leaders need to know to thrive in the new landscape. For more relevant insights on these topics, business leaders should also explore Genpact’s recent white paper titled ‘Break Boundaries with Generative AI.’ This episode is sponsored by Genpact. Learn how brands work with Emerj and other Emerj Media options at emerj.com/ad1.

Today’s guests include Kelly Cusick, Managing Director in Deloitte Consulting’s Actuarial & Insurance Solutions practice, and Michael Cline, Managing Director and Insurance Sector Claims Leader for Deloitte Consulting. Joining Emerj Senior Editor Matthew DeMello, they explain key trends in underwriting for our executive audience, emphasizing the evolution of personalization and the expanding reach of personal connections within the industry. Later in the discussion, the trio explores the transformative impact of new AI capabilities, shedding light on how these technologies enable insurance companies to streamline workflows and provide invaluable prescriptive insights for both underwriters and customers alike. This episode is sponsored by Deloitte. Learn how brands work with Emerj and other Emerj Media options at emerj.com/ad1.

Today’s guest is Andrew Bolt, Partner at Deloitte. He joins Emerj CEO and Head of Research Daniel Faggella on today’s podcast to talk about challenges in R&D  for life sciences. While productivity has remained stagnant for the last 10-15 years, advances in AI-enhanced protein structure prediction are revolutionizing drug targeting and the very infrastructure of recruiting patients for clinical trials. Later, the two postulate on the ways AI can expedite regulatory compliance in pharmaceutical R&D in similar ways. Find out more about sponsored content and how to engage with the Emerj audience at emerj.com/ad1.

Today’s guests on the ‘AI in Business’ podcast are Jennifer Bradshaw and Arash Kamiar, Director of Product and Senior Product Owner at NLP Logix, respectively. NLP Logix is a fast-growing AI services firm based in Florida that serves both the public and private sectors. They join Emerj Senior Matthew DeMello on today’s podcast to talk about developing AI solutions with what they call a ‘product mindset.’ Throughout the program, the pair emphasize shifting focus away from the unique technological capabilities of AI tools to the problems that customers suffer through every day and how those tools can be applied to solve them. This episode is sponsored by NLP Logix. Find out more about sponsored content and how to engage with the Emerj audience at emerj.com/ad1.

Today’s guest is Dr. Dan Elton, a Data Scientist at the Mass General Brigham Data Science Office. He’s also a fellow at the Foresight Institute and previously served as a staff scientist at the National Institutes of Health. He joins Emerj Senior Editor Matthew DeMello on today’s show to talk about promising AI use cases in healthcare, including use cases in radiology, compliance, and medical record generation, search, and summarization. Later, the two discuss how foundational models will transform how AI is used in radiology. To discover more AI use cases, best practice guides, white papers, frameworks, and more, join Emerj Plus at emerj.com/p1.

Today's guest is Bhuvanesh Abrol, US Private Equity Consulting Leader and US M&A Services Private Equity Consulting Leader at Deloitte. He joins Emerj CEO and Head of Research Daniel Faggella on today's program to talk about the AI opportunities in private equity investment decisions and deal-making. Later, the pair pull apart the fundamentals of using AI to inform opaque pricing in procurement and to drive increased collection rates. This episode is sponsored by Deloitte. Learn how brands work with Emerj and other Emerj Media options at emerj.com/ad1.

Today’s guests are Melissa Easy, Vice President and General Manager of Clinical Technologies and Vinita Navadgi, Sr. Director, Digital Patient Suite at IQVIA. They join us on today’s show to discuss the advantages of optimizing consent workflows through automation, or ‘eConsent’ processes. The conversation delves into the metrics defining the effectiveness of ‘eConsent’ for both patients and healthcare providers, elucidating the role of AI in shaping the broader landscape of clinical trials. If you’ve enjoyed or benefited from some of the insights of this episode, consider leaving us a five-star review on Apple Podcasts, and let us know what you learned, found helpful, or liked most about this show!

Today’s guest is Mark Miller, Managing Director of Life Science Advertising, Marketing & Commerce at Deloitte. He joins Emerj CEO and Head of Research Daniel Faggella on today’s podcast to discuss leveraging data in proven AI use cases in pharmaceutical sales and marketing, particularly when it comes to the ‘next best’ engagement. Throughout the episode, Mark emphasizes the importance of connected data and decision algorithms to engage with healthcare professionals more effectively. This episode is sponsored by Deloitte. Learn how brands work with Emerj and other Emerj Media options at emerj.com/ad1.

Today’s guest is John D’Angelo, Real Estate Solutions Leader at Deloitte. John joins Emerj CEO and Head of Research Daniel Faggella on today’s program to discuss the challenges and trends in the real estate industry, highlighting the local knowledge-heavy nature of the business. Throughout the episode, John emphasizes the true sources of friction to new technology adoption and the importance of storytelling in the sector. Later, the discussion delves into the leasing process, where AI can streamline the creation and understanding of complex leases, reducing labor and mitigating risks. This episode is sponsored by Deloitte. Learn how brands work with Emerj and other Emerj Media options at emerj.com/ad1.